We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.5B
AUM Growth
+$2.63B
Cap. Flow
-$358M
Cap. Flow %
-1.01%
Top 10 Hldgs %
19.61%
Holding
1,339
New
136
Increased
426
Reduced
527
Closed
93

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$78.4M
2
STLA icon
Stellantis
STLA
+$64.2M
3
AAPL icon
Apple
AAPL
+$56.5M
4
CINF icon
Cincinnati Financial
CINF
+$36.6M
5
MA icon
Mastercard
MA
+$33.9M

Top Sells

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$121M
2
EPAM icon
EPAM Systems
EPAM
+$65.3M
3
NVDA icon
NVIDIA
NVDA
+$47.2M
4
VLO icon
Valero Energy
VLO
+$46.8M
5
AMAT icon
Applied Materials
AMAT
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 30.16%
2 Healthcare 17.06%
3 Consumer Discretionary 12.32%
4 Financials 10.62%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHC icon
1026
Graham Holdings Company
GHC
$4.91B
$697K ﹤0.01%
1,100
-300
-21% -$193K
YPF icon
1027
YPF Sociedad Anonima ADS
YPF
$22.6B
$693K ﹤0.01%
+148,072
New +$666K
WTM icon
1028
White Mountains Insurance
WTM
$4.88B
$689K ﹤0.01%
600
-300
-33% -$350K
MXIM
1029
DELISTED
Maxim Integrated Products
MXIM
$674K ﹤0.01%
6,397
+708
+12% +$69.3K
TBI
1030
Trueblue
TBI
$276M
$669K ﹤0.01%
+23,800
New +$634K
VIV icon
1031
Telefônica Brasil
VIV
$19B
$653K ﹤0.01%
76,817
BNFT
1032
DELISTED
Benefitfocus, Inc.
BNFT
$650K ﹤0.01%
46,100
-4,000
-8% -$56.4K
DLR icon
1033
Digital Realty Trust
DLR
$66.5B
$641K ﹤0.01%
4,257
-94
-2% -$14.2K
WBS
1034
DELISTED
Webster Financial
WBS
$635K ﹤0.01%
+11,900
New +$660K
NBIX icon
1035
Neurocrine Biosciences
NBIX
$15.2B
$603K ﹤0.01%
6,200
+4,125
+199% +$395K
NHC icon
1036
National Healthcare
NHC
$3.55B
$601K ﹤0.01%
+8,600
New +$625K
RJF icon
1037
Raymond James Financial
RJF
$32.5B
$599K ﹤0.01%
6,918
+7
+0.1% +$609
BEKE icon
1038
KE Holdings
BEKE
$17.9B
$598K ﹤0.01%
+12,539
New +$641K
MBT
1039
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$597K ﹤0.01%
64,417
EBS icon
1040
Emergent Biosolutions
EBS
$326M
$592K ﹤0.01%
9,400
TDS icon
1041
Telephone and Data Systems
TDS
$4.35B
$591K ﹤0.01%
26,100
CALX icon
1042
Calix
CALX
$2.24B
$589K ﹤0.01%
12,400
NEU icon
1043
NewMarket
NEU
$8.13B
$580K ﹤0.01%
1,800
+200
+13% +$70K
SPOT icon
1044
Spotify
SPOT
$115B
$576K ﹤0.01%
2,091
+863
+70% +$219K
SKT icon
1045
Tanger
SKT
$4.16B
$574K ﹤0.01%
30,466
ALXN
1046
DELISTED
Alexion Pharmaceuticals
ALXN
$572K ﹤0.01%
3,115
-258,356
-99% -$44.3M
WSBC icon
1047
WesBanco
WSBC
$3.87B
$570K ﹤0.01%
16,000
+6,300
+65% +$236K
IDT icon
1048
IDT Corp
IDT
$1.77B
$569K ﹤0.01%
15,400
SGI
1049
Somnigroup International
SGI
$13.8B
$568K ﹤0.01%
+14,500
New +$556K
MDC
1050
DELISTED
M.D.C. Holdings, Inc.
MDC
$568K ﹤0.01%
11,232

Similar funds

Axa's Q2 2021 Portfolio in Review

As of Q2 2021, Axa held 1,339 positions worth $35.5B, up 8% from $32.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa's Q2 2021 filing shows 136 new, 426 increased, 527 reduced and 93 closed positions. Its largest new stake was Sprinklr: 1,100,000 shares worth $22.6M. The largest sale was Proofpoint, Inc., an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2021 buy was Sprinklr: 1,100,000 shares worth $22.6M.
  • Axa added most to Berkshire Hathaway Class B in Q2 2021, an estimated $78.4M increase.
  • Axa's biggest Q2 2021 reduction was Proofpoint, Inc., cutting an estimated $121M.
  • Axa fully exited Arthur J. Gallagher & Co in Q2 2021, selling an estimated $33.5M.
  • Axa's ten largest holdings make up 20% of its $35.5B portfolio in Q2 2021.
  • Axa opened 136 new positions and closed 93 in Q2 2021.
  • Axa's portfolio value rose 8% quarter-over-quarter to $35.5B.

Based on Axa's 13F filing for Q2 2021, filed 13 Aug 2021.